Search results
5 maj 2021 · A meta-analysis was performed to calculate the risk ratio (RR) and 95% confidence interval (CI) for binary outcomes and mean difference (MD) for continuous outcomes. Results : A total of 5 RCTs with 824 individuals with mild or moderate COVID 19 were included.
1 maj 2021 · Antibiotic prescribing was higher with increasing patient age (OR 1.45 per 10 year increase, 95% CI 1.18–1.77) and higher with increasing proportion of patients requiring mechanical ventilation (OR 1.33 per 10% increase, 95% CI 1.15–1.54). Estimated bacterial co-infection was 8.6% (95% CI 4.7–15.2%) from 31 studies.
28 maj 2021 · One prospective multicenter, randomized controlled trial (RCT) involving 284 patients with COVID-19 had shown that LH plus usual treatment could significantly improve the recovery rate (91.5% vs 82.4%) and short the time to symptom recovery (median: 7 days vs 10 days) as compared to usual treatment only. [8]
1 maj 2021 · Overall, treatment with LH capsules for 14 days resulted in a significantly higher rate of, and a shorter time to, symptom recovery than control group (usual treatment). The rate of recovery of fever, fatigue and coughing was also higher in treatment group.
28 maj 2021 · This study aimed to assess the efficacy and safety of LH combined with usual treatment vs usual treatment alone in treating mild or moderate COVID-19 by a meta-analysis of randomized controlled trials (RCTs). Methods and analysis: : We systematically searched the Medline (OVID), Embase, the Cochrane Library, and 4 Chinese databases from ...
1 lip 2022 · Lianhua Qingwen (LHQW) has been widely used in China and overseas Chinese, which had some advantages in the treatment of COVID-19. Objective. To evaluate the efficacy and safety of LHQW for COVID-19 by conducting a systematic review with meta-analysis. Methods.
15 sie 2020 · This is the first randomised controlled trial for assessment of the immunogenicity and safety of a candidate non-replicating adenovirus type-5 (Ad5)-vectored COVID-19 vaccine, aiming to determine an appropriate dose of the candidate vaccine for an efficacy study.
